{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T01:55:57Z","timestamp":1784339757560,"version":"3.55.0"},"reference-count":54,"publisher":"Elsevier BV","issue":"32","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Pediatric Infectious Disease Society of Thailand"},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/j.vaccine.2019.06.015","type":"journal-article","created":{"date-parts":[[2019,7,4]],"date-time":"2019-07-04T17:17:14Z","timestamp":1562260634000},"page":"4551-4560","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["An updated cost-effectiveness analysis of pneumococcal conjugate vaccine among children in Thailand"],"prefix":"10.1016","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6981-1771","authenticated-orcid":false,"given":"Piyameth","family":"Dilokthornsakul","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirati","family":"Kengkla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Surasak","family":"Saokaew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6909-2789","authenticated-orcid":false,"given":"Unchalee","family":"Permsuwan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chonnamet","family":"Techasaensiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tawee","family":"Chotpitayasunondh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4572-8794","authenticated-orcid":false,"given":"Nathorn","family":"Chaiyakunapruk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2019.06.015_b0005","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1097\/INF.0000000000000955","article-title":"Global burden of neonatal invasive pneumococcal disease: a systematic review and meta-analysis","volume":"35","author":"Billings","year":"2016","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2019.06.015_b0010","unstructured":"World health organization. Estimated Hib and pneumococcal deaths for children under 5 years of age; 2008."},{"key":"10.1016\/j.vaccine.2019.06.015_b0015","first-page":"355","article-title":"A comparison of population-based pneumonia surveillance and health-seeking behavior in two provinces in rural Thailand","volume":"13","author":"Jordan","year":"2009","journal-title":"In J Infect Dis IJID Official Publ Int Soc Infect Dis"},{"key":"10.1016\/j.vaccine.2019.06.015_b0020","first-page":"553","article-title":"Bacterial meningitis incidence in Thai children estimated by a rapid assessment tool (RAT)","volume":"40","author":"Muangchana","year":"2009","journal-title":"Southeast Asian J Trop Med Publ Health"},{"key":"10.1016\/j.vaccine.2019.06.015_b0025","doi-asserted-by":"crossref","first-page":"7282","DOI":"10.1016\/j.vaccine.2009.04.046","article-title":"Overview of the disease burden of invasive pneumococcal disease in Asia","volume":"27","author":"Bravo","year":"2009","journal-title":"Vaccine"},{"issue":"Suppl 2","key":"10.1016\/j.vaccine.2019.06.015_b0030","doi-asserted-by":"crossref","first-page":"S109","DOI":"10.1097\/INF.0000000000000078","article-title":"Systematic review of the effect of pneumococcal conjugate vaccine dosing schedules on vaccine-type invasive pneumococcal disease among young children","volume":"33","author":"Conklin","year":"2014","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2019.06.015_b0035","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1097\/INF.0b013e31824de9f6","article-title":"The worldwide impact of the seven-valent pneumococcal conjugate vaccine","volume":"31","author":"Fitzwater","year":"2012","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2019.06.015_b0040","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s41479-017-0030-5","article-title":"Pneumococcal conjugate vaccine implementation in middle-income countries","volume":"9","author":"Tricarico","year":"2017","journal-title":"Pneumonia (Nathan Qld)."},{"issue":"Suppl","key":"10.1016\/j.vaccine.2019.06.015_b0045","doi-asserted-by":"crossref","first-page":"211","DOI":"10.4161\/hv.7.0.14602","article-title":"Epidemiological changes after PCV7 implementation in Italy: perspective for new vaccines","volume":"7","author":"Ansaldi","year":"2011","journal-title":"Human Vacc"},{"key":"10.1016\/j.vaccine.2019.06.015_b0050","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/S1473-3099(11)70090-1","article-title":"Herd immunity and serotype replacement 4 years after seven-valent pneumococcal conjugate vaccination in England and Wales: an observational cohort study","volume":"11","author":"Miller","year":"2011","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2019.06.015_b0055","doi-asserted-by":"crossref","first-page":"e51","DOI":"10.1016\/S2214-109X(16)30306-0","article-title":"Indirect effects of childhood pneumococcal conjugate vaccination on invasive pneumococcal disease: a systematic review and meta-analysis","volume":"5","author":"Shiri","year":"2017","journal-title":"Lancet Global Health"},{"key":"10.1016\/j.vaccine.2019.06.015_b0060","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1586\/erv.09.113","article-title":"10-valent pneumococcal nontypeable Haemophilus influenzae PD conjugate vaccine: synflorix","volume":"8","author":"Prymula","year":"2009","journal-title":"Exp Rev Vacc"},{"key":"10.1016\/j.vaccine.2019.06.015_b0065","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1345\/aph.1Q347","article-title":"Prevnar 13, the new 13-valent pneumococcal conjugate vaccine","volume":"45","author":"Sucher","year":"2011","journal-title":"Ann Pharmacoth"},{"key":"10.1016\/j.vaccine.2019.06.015_b0070","unstructured":"Johns Hopkins Bloomberg School of Public Health \u2013 IVAC: Interactive Vaccines Access Center (View-Hub) data."},{"key":"10.1016\/j.vaccine.2019.06.015_b0075","unstructured":"World Health Organization. PRIME Study: PCV Review of Impact Evidence."},{"key":"10.1016\/j.vaccine.2019.06.015_b0080","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1007\/s40273-016-0439-3","article-title":"Cost Effectiveness of pneumococcal vaccination in children in low- and middle-income countries: a systematic review","volume":"34","author":"Saokaew","year":"2016","journal-title":"PharmacoEconomics"},{"key":"10.1016\/j.vaccine.2019.06.015_b0085","doi-asserted-by":"crossref","first-page":"2839","DOI":"10.1016\/j.vaccine.2013.03.047","article-title":"Cost-utility analysis of 10- and 13-valent pneumococcal conjugate vaccines: protection at what price in the Thai context?","volume":"31","author":"Kulpeng","year":"2013","journal-title":"Vaccine"},{"issue":"Suppl 5","key":"10.1016\/j.vaccine.2019.06.015_b0090","first-page":"S50","article-title":"Handling time in economic evaluation studies","volume":"97","author":"Permsuwan","year":"2014","journal-title":"J Med Assoc Thailand = Chotmaihet Thangphaet"},{"issue":"Suppl 2","key":"10.1016\/j.vaccine.2019.06.015_b0095","first-page":"S16","article-title":"Defining the scope of economic evaluation study and selection of comparators","volume":"91","author":"Chaiyakunapruk","year":"2008","journal-title":"J Med Assoc Thailand = Chotmaihet Thangphaet"},{"key":"10.1016\/j.vaccine.2019.06.015_b0100","first-page":"886","article-title":"Acute bacterial meningitis in adults: a 20 year review","volume":"35","author":"Khwannimit","year":"2004","journal-title":"Southeast Asian J Trop Med Publ Health"},{"key":"10.1016\/j.vaccine.2019.06.015_b0105","doi-asserted-by":"crossref","first-page":"e66038","DOI":"10.1371\/journal.pone.0066038","article-title":"Pneumococcal bacteremia requiring hospitalization in rural Thailand: an update on incidence, clinical characteristics, serotype distribution, and antimicrobial susceptibility, 2005\u20132010","volume":"8","author":"Rhodes","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2019.06.015_b0110","series-title":"Burden of disease and injuries in Thailand 2004","author":"Working group of Burden of Disease Project","year":"2007"},{"key":"10.1016\/j.vaccine.2019.06.015_b0115","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/S0140-6736(12)61854-6","article-title":"Effectiveness of the ten-valent pneumococcal Haemophilus influenzae protein D conjugate vaccine (PHiD-CV10) against invasive pneumococcal disease: a cluster randomised trial","volume":"381","author":"Palmu","year":"2013","journal-title":"Lancet (London, England)."},{"key":"10.1016\/j.vaccine.2019.06.015_b0120","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1056\/NEJMoa1209165","article-title":"hospitalizations for pneumonia after a decade of pneumococcal vaccination","volume":"369","author":"Griffin","year":"2013","journal-title":"New Engl J Med"},{"key":"10.1016\/j.vaccine.2019.06.015_b0125","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.4161\/hv.28675","article-title":"Changing trends in serotype distribution and antimicrobial susceptibility of Streptococcus pneumoniae causing invasive diseases in Central Thailand, 2009\u20132012","volume":"10","author":"Phongsamart","year":"2014","journal-title":"Human Vacc Immunother"},{"issue":"Suppl 2","key":"10.1016\/j.vaccine.2019.06.015_b0130","doi-asserted-by":"crossref","first-page":"S65","DOI":"10.1086\/596484","article-title":"Incidence of pneumococcal bacteremia requiring hospitalization in rural Thailand","volume":"48","author":"Baggett","year":"2009","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"key":"10.1016\/j.vaccine.2019.06.015_b0135","first-page":"311","article-title":"Wastage of multi-dose measles vaccine survey in public health facilities","volume":"34","author":"Techathawat","year":"2008","journal-title":"Dis Control J"},{"key":"10.1016\/j.vaccine.2019.06.015_b0140","series-title":"Thailand's National Health Technology assessment guidelines","year":"2009"},{"issue":"Suppl 5","key":"10.1016\/j.vaccine.2019.06.015_b0145","first-page":"S127","article-title":"Standard cost lists for health economic evaluation in Thailand","volume":"97","author":"Riewpaiboon","year":"2014","journal-title":"J Med Assoc Thailand = Chotmaihet Thangphaet"},{"key":"10.1016\/j.vaccine.2019.06.015_b0150","doi-asserted-by":"crossref","first-page":"8993","DOI":"10.7314\/APJCP.2014.15.20.8993","article-title":"Economic evaluation and budget impact analysis of the surveillance program for hepatocellular carcinoma in Thai chronic hepatitis B patients","volume":"15","author":"Sangmala","year":"2014","journal-title":"Asian Pacif J Canc Prev APJCP"},{"key":"10.1016\/j.vaccine.2019.06.015_b0155","doi-asserted-by":"crossref","first-page":"29","DOI":"10.2147\/CEOR.S38062","article-title":"Estimating the willingness to pay for a quality-adjusted life year in Thailand: does the context of health gain matter?","volume":"5","author":"Thavorncharoensap","year":"2013","journal-title":"ClinicoEcon Outcomes Res CEOR"},{"key":"10.1016\/j.vaccine.2019.06.015_b0160","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/S0140-6736(06)68304-9","article-title":"Pneumococcal capsular polysaccharides conjugated to protein D for prevention of acute otitis media caused by both Streptococcus pneumoniae and non-typable Haemophilus influenzae: a randomised double-blind efficacy study","volume":"367","author":"Prymula","year":"2006","journal-title":"Lancet (London, England)."},{"key":"10.1016\/j.vaccine.2019.06.015_b0165","doi-asserted-by":"crossref","first-page":"e0120290","DOI":"10.1371\/journal.pone.0120290","article-title":"Impact of ten-valent pneumococcal conjugate vaccination on invasive pneumococcal disease in Finnish children\u2013a population-based study","volume":"10","author":"Jokinen","year":"2015","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2019.06.015_b0170","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.3201\/eid2111.140780","article-title":"Invasive pneumococcal disease 3 years after introduction of 10-valent pneumococcal conjugate vaccine, the Netherlands","volume":"21","author":"Knol","year":"2015","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2019.06.015_b0175","series-title":"Decision modelling for health economic evaluation","author":"Briggs","year":"2006"},{"key":"10.1016\/j.vaccine.2019.06.015_b0180","doi-asserted-by":"crossref","first-page":"6686","DOI":"10.1016\/j.vaccine.2011.06.091","article-title":"Cost-effectiveness of conjugate pneumococcal vaccination in Singapore: comparing estimates for 7-valent, 10-valent, and 13-valent vaccines","volume":"29","author":"Tyo","year":"2011","journal-title":"Vaccine."},{"key":"10.1016\/j.vaccine.2019.06.015_b0185","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1080\/21645515.2015.1067351","article-title":"Cost-effectiveness analysis of infant universal routine pneumococcal vaccination in Malaysia and Hong Kong","volume":"12","author":"Wu","year":"2016","journal-title":"Human Vacc Immunother"},{"key":"10.1016\/j.vaccine.2019.06.015_b0190","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1080\/21645515.2015.1048937","article-title":"Surveillance of adverse events following the introduction of 13-valent pneumococcal conjugate vaccine in infants, and comparison with adverse events following 7-valent pneumococcal conjugate vaccine, in Victoria, Australia","volume":"11","author":"Littlejohn","year":"2015","journal-title":"Human Vacc Immunother"},{"key":"10.1016\/j.vaccine.2019.06.015_b0195","doi-asserted-by":"crossref","first-page":"107","DOI":"10.2174\/1574886313666180406164151","article-title":"Register-based ecologic evaluation of safety signals related to pneumococcal conjugate vaccine in children","volume":"13","author":"Artama","year":"2018","journal-title":"Curr Drug Saf."},{"issue":"9","key":"10.1016\/j.vaccine.2019.06.015_b0200","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1093\/cid\/ciy743","article-title":"Safety and immunogenicity of pneumococcal conjugate vaccines in a high-risk population: a randomized controlled trial of 10-valent and 13-valent PCV in Papua New Guinean infants","volume":"68","author":"Pomat","year":"2019","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2019.06.015_b0205","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1016\/j.vaccine.2015.01.081","article-title":"Choosing between 7-, 10- and 13-valent pneumococcal conjugate vaccines in childhood: a review of economic evaluations (2006\u20132014)","volume":"33","author":"Wu","year":"2015","journal-title":"Vaccine."},{"key":"10.1016\/j.vaccine.2019.06.015_b0210","unstructured":"Center of Disease Control and Prevention. Global Pneumococcal Disease and Vaccine; 2018."},{"key":"10.1016\/j.vaccine.2019.06.015_b0215","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1367\/1539-4409(2002)002<0358:PVOFBA>2.0.CO;2","article-title":"Pediatricians' views on financial barriers and values for pneumococcal vaccine for children","volume":"2","author":"Lieu","year":"2002","journal-title":"Ambul Pediatr."},{"key":"10.1016\/j.vaccine.2019.06.015_b0220","doi-asserted-by":"crossref","first-page":"137","DOI":"10.2217\/cer.12.10","article-title":"Using health technology assessment for informing coverage decisions in Thailand","volume":"1","author":"Mohara","year":"2012","journal-title":"J Comp Eff Res."},{"key":"10.1016\/j.vaccine.2019.06.015_b0225","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1586\/14737167.2016.1120672","article-title":"Cost-utility and budget impact analysis of drug treatments in pulmonary arterial hypertension associated with congenital heart diseases in Thailand","volume":"16","author":"Thongsri","year":"2016","journal-title":"Exp Rev Pharmacoecon Outcomes Res."},{"key":"10.1016\/j.vaccine.2019.06.015_b0230","doi-asserted-by":"crossref","first-page":"289","DOI":"10.3389\/fpubh.2017.00289","article-title":"Economic evaluation and budget impact analysis of vaccination against Haemophilus influenzae Type b infection in Thailand","volume":"5","author":"Kotirum","year":"2017","journal-title":"Front Public Health."},{"key":"10.1016\/j.vaccine.2019.06.015_b0235","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1186\/1472-6963-10-209","article-title":"A cost-utility and budget impact analysis of allogeneic hematopoietic stem cell transplantation for severe thalassemic patients in Thailand","volume":"10","author":"Leelahavarong","year":"2010","journal-title":"BMC Health Serv Res."},{"key":"10.1016\/j.vaccine.2019.06.015_b0240","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1007\/s40261-016-0401-3","article-title":"Economic evaluation of intravenous immunoglobulin plus corticosteroids for the treatment of steroid-resistant chronic inflammatory demyelinating polyradiculoneuropathy in Thailand","volume":"36","author":"Bamrungsawad","year":"2016","journal-title":"Clin Drug Investig."},{"key":"10.1016\/j.vaccine.2019.06.015_b0245","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/s40273-015-0269-8","article-title":"Cost-utility analysis of intravenous immunoglobulin for the treatment of steroid-refractory dermatomyositis in Thailand","volume":"33","author":"Bamrungsawad","year":"2015","journal-title":"PharmacoEconomics."},{"key":"10.1016\/j.vaccine.2019.06.015_b0250","doi-asserted-by":"crossref","first-page":"e1103","DOI":"10.1542\/peds.2008-3422","article-title":"Efficacy of pneumococcal vaccination in children younger than 24 months: a meta-analysis","volume":"123","author":"Pavia","year":"2009","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2019.06.015_b0255","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1097\/01.inf.0000232706.35674.2f","article-title":"Effectiveness of heptavalent pneumococcal conjugate vaccine in children younger than 5 years of age for prevention of pneumonia: updated analysis using World Health Organization standardized interpretation of chest radiographs","volume":"25","author":"Hansen","year":"2006","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2019.06.015_b0260","doi-asserted-by":"crossref","first-page":"e1001657","DOI":"10.1371\/journal.pmed.1001657","article-title":"Efficacy of pneumococcal nontypable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) in young Latin American children: a double-blind randomized controlled trial","volume":"11","author":"Tregnaghi","year":"2014","journal-title":"PLoS Med"},{"key":"10.1016\/j.vaccine.2019.06.015_b0265","series-title":"V3P vaccine product, price and procurement database","author":"World Health Orgarnization","year":"2018"},{"key":"10.1016\/j.vaccine.2019.06.015_b0270","series-title":"Technology Division (EMTD) Department of Medical Services MoH","author":"Essential Medicines and","year":"2018"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19307765?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19307765?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,20]],"date-time":"2019-09-20T09:39:06Z","timestamp":1568972346000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X19307765"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":54,"journal-issue":{"issue":"32","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["S0264410X19307765"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.06.015","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An updated cost-effectiveness analysis of pneumococcal conjugate vaccine among children in Thailand","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.06.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}